These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8935868)

  • 1. [Example of teratogen detection using a birth defects registry: depakine and spina bifida].
    Robert E
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S78-81. PubMed ID: 8935868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Registries of malformations in the Rhône-Alps/Auvergne region. Value and limits of monitoring teratogenesis. 11 years' experience (1976-1986)].
    Robert E; Francannet C; Robert JM
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(5):601-7. PubMed ID: 3230269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
    Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
    Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratogen update: valproic acid.
    Lammer EJ; Sever LE; Oakley GP
    Teratology; 1987 Jun; 35(3):465-73. PubMed ID: 3114906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States.
    Gilboa SM; Broussard CS; Devine OJ; Duwe KN; Flak AL; Boulet SL; Moore CA; Werler MM; Honein MA
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):234-46. PubMed ID: 21766433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
    Jentink J; Bakker MK; Nijenhuis CM; Wilffert B; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):803-7. PubMed ID: 20680999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal carbamazepine and infant spina bifida.
    Källén AJ
    Reprod Toxicol; 1994; 8(3):203-5. PubMed ID: 8075508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spina bifida: anticonvulsants and other maternal influences.
    Holmes LB
    Ciba Found Symp; 1994; 181():232-8; discussion 239-44. PubMed ID: 8005027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine reduces the valproic acid-induced spina bifida rate in mice without altering valproic acid kinetics.
    Ehlers K; Elmazar MM; Nau H
    J Nutr; 1996 Jan; 126(1):67-75. PubMed ID: 8558327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Teratogenic risks of epilepsy and anticonvulsants].
    Robert E
    Pediatrie; 1991; 46(8-9):579-83. PubMed ID: 1660115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal ultrasonographic diagnosis in the epileptic mother on valproic acid. Retrospective study of 161 cases in the central eastern France register of congenital malformations].
    Bradaï R; Robert E
    J Gynecol Obstet Biol Reprod (Paris); 1998 Jun; 27(4):413-9. PubMed ID: 9690160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of spina bifida in Sweden 1973-2003: the effect of prenatal diagnosis.
    Nikkilä A; Rydhström H; Källén B
    Eur J Public Health; 2006 Dec; 16(6):660-2. PubMed ID: 16672253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal diagnosis of 4 cases of spina bifida in mothers treated with valproate].
    Guibaud S; Simplot A; Boisson C; Pison H
    J Genet Hum; 1987 Aug; 35(4):231-5. PubMed ID: 2443614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spina bifida and cleft lip among newborns of Norwegian women with epilepsy: changes related to the use of anticonvulsants.
    King PB; Lie RT; Irgens LM
    Am J Public Health; 1996 Oct; 86(10):1454-6. PubMed ID: 8876519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan.
    Kondo A; Morota N; Ihara S; Saisu T; Inoue K; Shimokawa S; Fujimaki H; Matsuo K; Shimosuka Y; Watanabe T
    Birth Defects Res A Clin Mol Teratol; 2013 Sep; 97(9):610-5. PubMed ID: 24078478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of neural tube defects in Israel.
    Zlotogora J; Amitai Y; Kaluski DN; Leventhal A
    Isr Med Assoc J; 2002 Dec; 4(12):1111-4. PubMed ID: 12516902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring.
    Artama M; Auvinen A; Raudaskoski T; Isojärvi I; Isojärvi J
    Neurology; 2005 Jun; 64(11):1874-8. PubMed ID: 15955936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate and spina bifida.
    Drug Ther Bull; 1990 Jul; 28(15):59-60. PubMed ID: 2131215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.